Corporate Banner
Satellite Banner
Technology Networks Header
Monday, January 26, 2015
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Irvine Scientific Introduces PRIME-XV® T Cell Culture Medium
Wednesday, January 21, 2015
A xeno-free and serum-free medium for immunotherapy applications.

ZEISS Introduces Compact Confocal Microscope ZEISS LSM 800 with Airyscan
Saturday, January 17, 2015
Best imaging quality and fast linear scanning.

Newly Developed Bioactive Protein Surfaces for Cell Culture Growth
Friday, January 16, 2015
Reliable and consistent growth media for assay development, biomedical and cell biology applications.

Bioactive Protein Surfaces For Cell Culture Growth
Thursday, January 15, 2015
Orla Protein Technologies has developed an expanded range of cell culture surfaces.

‘Small and Simple’: Watson-Marlow’s 120 Peristaltic Pump
Tuesday, January 13, 2015
Ultimately the 120 pumps have been developed to increase the low-flow capabilities of the company's product range for applications in the biopharm sector. The market need for the 120 range is well understood, with customers voicing their own mantra, "keep it small, keep it simple". As a result, Watson-Marlow has produced a pump that is focused on size, performance and ease-of-use.

Bruker Introduces BioScope Resolve High-Resolution BioAFM System
Friday, December 26, 2014
Featuring PeakForce Tapping for quantitative bio-mechanical property mapping.

Tissue Culture Plastics & Epigenetic Supplies
Tuesday, December 23, 2014
New 2015 catalogue from Porvair Sciences.

Bio-Rad Launches Easy-to-Use PureBlu™ Nuclear Staining Dyes
Tuesday, December 16, 2014
High purity, pre-aliquoted formulations for cell imaging experiments.

Leica Microsystems Previews Light Sheet Module for Confocal Microscope
Tuesday, December 09, 2014
Technology preview at ASCB annual meeting.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 269
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn